The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
Through the records of (b)(4) it was learned that a 25mm 7300tfx was explanted after an implant duration of 8 years and 1 month due too dehiscence, severe large paravalvular regurgitation, and thicken leaflets.The explanted valve was replaced with a non-edwards mitral valve.Per medical records, the patient presented with heart failure nyha ii, and underwent a redo avr and mvr, tvr (severe regurgitation), and maze procedure.Intraoperatively the 19mm 3300tfx valve ((b)(4)) had a large amount of pannus underneath the valve which was excised, the leaflets were thickened.The aortic root was too small, trying to put a 21mm would have obstructed the coronary, so a 19mm 11500a was implanted and considered good for her bsa.The 25mm 7300tfx ((b)(4)) had dehiscence on the posteromedial aspect and it was very clear that the stitches on the posteromedial side had cut through the annulus.The leaflets were thickened.The mitral valve was replaced with a 27mm nonedwards ( st jude epic) valve.The tricuspid repair was performed with a 30mm mc3 annuloplasty ring.Patient transferred to the cvicu post-op.On pod #10, the patient discharged home in stable condition with 81mg aspirin qd, and eliquis qd for 30 days.
|
The device history record (dhr) review was completed, and this device passed all manufacturing and sterilization inspections prior to release for distribution.There were no issues identified that would have impacted this event.Device dehiscence or suture torn out may occur early or late.When it occurs in the intraoperative period, it is typically a result of inadequate device implantation in combination with friable myocardial tissue.Valve dehiscence is not a malfunction related to a manufacturing deficiency of the device.Edwards will continue to review and monitor all reported events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|